Suchergebnisse - "Aiello, Marco"

PubPharm (10)

1

A pathomic approach for tumor-infiltrating lymphocytes classification on breast cancer digital pathology images

enthalten in: Heliyon | 2023

von Verdicchio, M. | Brancato, V. | Cavaliere, C. | +3

2

Associations Between Dynamic Contrast Enhanced Magnetic Resonance Imaging and Clinically Relevant Histopathological Features in Breast Cancer : A Multicenter Analysis

enthalten in: In vivo (Athens, Greece) | 2022

von Surov, A. | Kim, J. | Aiello, M. | +4

3

Breast cancer vaccines : Heeding the lessons of the past to guide a path forward

enthalten in: Cancer treatment reviews | 2020

von Solinas, C. | Aiello, M. | Migliori, E. | +2

4

Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype : a PET/MRI study

enthalten in: European journal of nuclear medicine and molecular imaging | 2018

von Incoronato, M. | Grimaldi, A. | Cavaliere, C. | +9

5

Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study

enthalten in: European journal of nuclear medicine & molecular imaging | 2018

von Incoronato, M. | Grimaldi, A. | Cavaliere, C. | +9

6

Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study

enthalten in: European journal of nuclear medicine and molecular imaging | 2018

von Incoronato, M. | Grimaldi, A. | Cavaliere, C. | +9

7

Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study

enthalten in: European journal of nuclear medicine and molecular imaging | 2018

von Incoronato, M. | Grimaldi, A. | Cavaliere, C. | +9

8

CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients

enthalten in: BMC cancer | 2014

von Incoronato, M. | Mirabelli, P. | Catalano, O. | +4

9

CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients

enthalten in: BMC cancer | 2014

von Incoronato, M. | Mirabelli, P. | Catalano, O. | +4

10

Comparison of whole-body PET/CT and PET/MRI in breast cancer patients : lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues

enthalten in: European journal of radiology | 2014

von Pace, L. | Nicolai, E. | Luongo, A. | +4

1
[1]